<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Treatment protocols for soft tissue and bone sarcoma
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Treatment protocols for soft tissue and bone sarcoma
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Treatment protocols for soft tissue and bone sarcoma
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Tim Brenner, PharmD, BCOP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shrina Duggal, PharmD, BCOP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jim Natale, PharmD, BCOP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert Maki, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Melinda Yushak, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H8525761">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following material represents a subset of chemotherapy and immunotherapy regimens that are used for the treatment of adult patients with soft tissue and bone sarcomas.
         <strong>
          This is
         </strong>
         <strong>
          not an exhaustive list
         </strong>
         ; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of patients with sarcomas. Additional regimens may be added over time, particularly as treatment for bone and soft tissue sarcoma evolves.
        </p>
        <p>
         This topic review is intended to provide only a listing of chemotherapy and immunotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with sarcomas. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7732.html" rel="external">
          "Treatment of locally recurrent and unresectable, locally advanced soft tissue sarcoma of the extremities"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7743.html" rel="external">
          "Overview of the initial treatment of metastatic soft tissue sarcoma"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7720.html" rel="external">
          "Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7723.html" rel="external">
          "Chemotherapy and radiation therapy in the management of osteosarcoma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy and immunotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy and immunotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.
        </p>
        <p class="headingAnchor" id="H8525768">
         <span class="h1">
          REGIMENS
         </span>
        </p>
        <p class="headingAnchor" id="H85120418">
         <span class="h2">
          Bone sarcomas
         </span>
        </p>
        <p class="headingAnchor" id="H825943302">
         <span class="h3">
          Doxorubicin plus cisplatin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef87182" href="/z/d/graphic/87182.html" rel="external">
          table 1
         </a>
         )
        </p>
        <p class="headingAnchor" id="H463344128">
         <span class="h3">
          Methotrexate plus doxorubicin and cisplatin (MAP)
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef87346" href="/z/d/graphic/87346.html" rel="external">
          table 2
         </a>
         )
        </p>
        <p class="headingAnchor" id="H85120378">
         <span class="h2">
          Soft tissue sarcomas
         </span>
        </p>
        <p class="headingAnchor" id="H936759827">
         <span class="h3">
          Doxorubicin (Adriamycin) plus ifosfamide and mesna (AIM 60/6)
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef56240" href="/z/d/graphic/56240.html" rel="external">
          table 3
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936759852">
         <span class="h3">
          Doxorubicin (Adriamycin) plus ifosfamide and mesna (AIM 75/9)
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef67985" href="/z/d/graphic/67985.html" rel="external">
          table 4
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936759877">
         <span class="h3">
          Doxorubicin (Adriamycin) plus ifosfamide and mesna (AIM 75/10)
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef81370" href="/z/d/graphic/81370.html" rel="external">
          table 5
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936759902">
         <span class="h3">
          Gemcitabine plus docetaxel
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef58713" href="/z/d/graphic/58713.html" rel="external">
          table 6
         </a>
         )
        </p>
        <p class="headingAnchor" id="H7613292">
         <span class="h3">
          Pegylated liposomal doxorubicin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef88268" href="/z/d/graphic/88268.html" rel="external">
          table 7
         </a>
         )
        </p>
        <p class="headingAnchor" id="H3871854348">
         <span class="h3">
          Trabectedin regimen for unresectable or metastatic liposarcoma or leiomyosarcoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef119711" href="/z/d/graphic/119711.html" rel="external">
          table 8
         </a>
         )
        </p>
        <p class="headingAnchor" id="H1955795169">
         <span class="h3">
          Weekly paclitaxel for angiosarcoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef95037" href="/z/d/graphic/95037.html" rel="external">
          table 9
         </a>
         )
        </p>
        <p class="headingAnchor" id="H3343880711">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Scott M Wirth, PharmD, BCOP, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div id="topicVersionRevision">
        Topic 85692 Version 25.0
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
